Cpa Global
Patent Analyst - Biotechnology and Biology and Life Sciences
Obalon Therapeutics Jun 1, 2015 - May 2018
Registered Patent Agent | Patent Drafting and Prosecution | Ip Portfolio Management | Litigation Support
Law Office of John C Mcmahon Feb 2009 - Jun 2015
Patent Agent
Dexcom May 2005 - Dec 2008
Patent Agent
Acon Laboratories Jul 2002 - May 2005
Patent Agent
Education:
Vanderbilt University 1990 - 2000
Doctorates, Doctor of Philosophy, Biochemistry
Texas A&M University Galveston Campus 1986 - 1990
Doctorates, Doctor of Philosophy, Mathematics
The University of Texas Medical Branch 1986 - 1990
Doctorates, Doctor of Philosophy, Mathematics
University of Houston 1986 - 1990
Doctorates, Doctor of Philosophy, Mathematics
Macalester College 1980 - 1984
Bachelors, Bachelor of Arts, Anthropology
Skills:
Patents Patent Prosecution Biotechnology Intellectual Property Medical Devices Patent Applications R&D Patentability Research Biochemistry Prosecution Biomedical Engineering Litigation Prior Art Search Project Management Patentability Searches Due Diligence Drafting Patent Applications Freedom To Operate Analysis Novelty Search Patent Searching Patent Portfolio Analysis Patent Portfolio Development Freedom To Operate Office Action Responses
Interests:
Exercise Medicine Electronics Home Improvement Diet Reading Fitness Collecting Home Decoration Health
Peter C. Simpson - Encinitas CA, US Richard C. Yang - Irvine CA, US Bradley Shigeto Matsubara - Escondido CA, US Robert Boock - San Diego CA, US Eleanor McCarthy - Overland Park KS, US Mark Brister - Encinitas CA, US
Assignee:
DexCom, Inc. - San Diego CA
International Classification:
A61B 5/145 A61B 5/00
US Classification:
600301, 600309
Abstract:
Systems and methods for continuous measurement of a medicament in vivo are provided. In some embodiments, the system is configured to provide information associated with medicament titration and includes a continuous analyte sensor and a communication device. In some embodiments, the system is configured for continuous ambulatory drug testing, including an ambulatory host monitor having a continuous sensor, a location module, a processor module and a transmitter. In some embodiments, the system is configured for continuously monitoring a hormone level and includes a continuous hormone sensor and a communication device configured to output hormone information in real time. Yet another embodiment provides an analyte sensor for continuous monitoring of a host's nutritional status, and is configured for both continuous glucose detection and continuous albumin detection.